Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancer
Oncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03772-2
Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancerOncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03772-2
Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancerOncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03725-9
HERC1 oncogene enhances stemness and tumorigenic potential in CD44+-derived organoids of head and neck squamous cell carcinoma through IL-6/STAT3 signalingOncogene, Published online: 10 April 2026; doi:10.1038/s41388-026-03731-x
Wnt signaling and the tumor microenvironment: implications for cancer progression and therapeuticsOncogene, Published online: 10 April 2026; doi:10.1038/s41388-026-03771-3
The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epitheliumOncogene, Published online: 09 April 2026; doi:10.1038/s41388-026-03775-z
Plasmin promotes hepatocellular carcinoma invasion and metastasis via CXCR4-mediated activation of PI3K/AKT/mTOR signalingOncogene, Published online: 08 April 2026; doi:10.1038/s41388-026-03758-0
Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active playerOncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03753-5
PIAS4 inhibition induces cell cycle arrest and exhibits a synergistic effect in combination with CDK4/6 inhibitor in breast cancer treatmentOncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03762-4
NSUN2/ALYREF-mediated RNA m5c modification promotes anoikis resistance of prostate cancer through activating autophagyOncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03760-6
Hypoxia-induced XBP1s-MYDGF axis suppresses ferroptosis through UBQLN1-mediated stabilization of LCN2 in gastric cancerOncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03759-z
SETDB2 induces abnormal SHP-1 splicing and promotes immunosuppression in hepatocellular carcinomaOncogene, Published online: 06 April 2026; doi:10.1038/s41388-026-03767-z
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcomaOncogene, Published online: 06 April 2026; doi:10.1038/s41388-026-03768-y
Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stressOncogene, Published online: 06 April 2026; doi:10.1038/s41388-026-03735-7
SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activationOncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03763-3
Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic stateOncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03747-3
Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancerOncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03766-0
S100A6 promotes liver metastasis by activating FGFR3 signaling in BAP1-deficient uveal melanomaOncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03742-8
Deciphering functional intra-tumoral heterogeneity in BRAFV600E-driven mouse thyroid cancer reveals EMT trajectory and metabolic remodelingOncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03764-2
Spliceosomal component SNRPE drives cell proliferation by regulating CTP synthase 1 mRNA splicing in ovarian cancerOncogene, Published online: 03 April 2026; doi:10.1038/s41388-026-03743-7
TWIST1 mediated transcriptional activation of SPON2 drives colorectal cancer peritoneal metastasis through stromal cell signaling networkOncogene, Published online: 03 April 2026; doi:10.1038/s41388-026-03732-w
The role of Rho-associated coiled-coil kinases (ROCK) in cancer